CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.
Also called NCT05066789
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05066789
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Terminated
Technical summary
Registry record NCT05066789. Randomized; no masking; primary purpose treatment. Start 2022-01-17 (actual); primary completion 2024-03-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
- Acronym
- SMART-CHOICE4
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Type of stent
- Intervention (Drug)
- Duration of DAPT
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct05066789- Content hash
273e337451d1e85cfa242bca8f1acd4345344e76fa7e3b1ba564c280d83a9c4b